Public Policy: Vitamins for the Drugmakers

Last August the Justice Department's Antitrust Division brought suit against three major drug makers—American Cyanamid. Bristol-Myers and Chas. Pfizer & Co.—on charges that they had conspired to fix prices of three "broad spectrum" antibiotics. The trustbusters' charges were similar to those that the Federal Trade Commission had been pressing since 1958 against six drug companies—including the three under fire from Justice. Last week the drug industry got a shot in the arm when FTC Hearing Examiner Robert Piper ordered dismissal of the FTC charges.

After wading through 19,000 pages of testimony and...

Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!